4//SEC Filing
Kopczynski Casey C. 4
Accession 0001209191-21-011401
CIK 0001337553other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 5:40 PM ET
Size
8.5 KB
Accession
0001209191-21-011401
Insider Transaction Report
Form 4
Kopczynski Casey C.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2021-02-15$0.20/sh+60,651$11,888→ 265,522 total - Tax Payment
Common Stock
2021-02-15$16.41/sh−725$11,897→ 264,797 total - Exercise/Conversion
Stock Option (right to buy)
2021-02-15−60,651→ 0 totalExercise: $0.20Exp: 2021-04-28→ Common Stock (60,651 underlying)
Footnotes (1)
- [F1]This option is fully vested and exercisable. If not exercised, the option would have expired on April 28, 2021.
Documents
Issuer
AERIE PHARMACEUTICALS INC
CIK 0001337553
Entity typeother
Related Parties
1- filerCIK 0001590001
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 5:40 PM ET
- Size
- 8.5 KB